| Primary |
| Atrial Fibrillation |
33.3% |
| Gout |
33.3% |
| Mitral Valve Replacement |
33.3% |
|
| International Normalised Ratio Increased |
100.0% |
|
| Secondary |
| Herpes Zoster |
13.5% |
| Hypertension |
11.2% |
| Drug Use For Unknown Indication |
9.0% |
| Product Used For Unknown Indication |
9.0% |
| Atrial Fibrillation |
6.7% |
| Gout |
6.7% |
| Immunosuppression |
5.6% |
| Eczema Infantile |
4.5% |
| Hyperlipidaemia |
4.5% |
| Constipation |
3.4% |
| Dyslipidaemia |
3.4% |
| Oedema Peripheral |
3.4% |
| Pain In Extremity |
3.4% |
| Peripheral Arterial Occlusive Disease |
3.4% |
| Renal Impairment |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Hyperuricaemia |
2.2% |
| Anaemia |
1.1% |
| Back Pain |
1.1% |
| Mitral Valve Replacement |
1.1% |
|
| Renal Failure Acute |
22.2% |
| Autoimmune Hepatitis |
11.1% |
| Blood Immunoglobulin G Increased |
11.1% |
| Renal Failure |
11.1% |
| Vomiting |
11.1% |
| Blood Lactate Dehydrogenase Increased |
5.6% |
| Haematemesis |
5.6% |
| Neonatal Tachypnoea |
5.6% |
| Potentiating Drug Interaction |
5.6% |
| Small For Dates Baby |
5.6% |
| Transaminases Increased |
5.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.1% |
| Hypertension |
13.5% |
| Hiv Infection |
12.2% |
| Hyperuricaemia |
12.0% |
| Product Used For Unknown Indication |
7.1% |
| Cardiac Failure |
5.1% |
| Rheumatoid Arthritis |
3.9% |
| Prophylaxis |
3.8% |
| Prophylaxis Against Transplant Rejection |
3.2% |
| Renal Transplant |
3.2% |
| Cardiac Failure Chronic |
2.9% |
| Protein S Deficiency |
2.3% |
| Gout |
2.2% |
| Hyperlipidaemia |
2.2% |
| Insomnia |
2.2% |
| Immunosuppression |
2.0% |
| Kidney Transplant Rejection |
2.0% |
| Asthma |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Hepatitis C |
1.6% |
|
| Hepatic Function Abnormal |
7.3% |
| Pyrexia |
7.3% |
| Renal Failure Acute |
7.3% |
| Rhabdomyolysis |
7.3% |
| Cranial Nerve Palsies Multiple |
6.1% |
| White Blood Cell Count Decreased |
6.1% |
| Hyperlipidaemia |
4.9% |
| Interstitial Lung Disease |
4.9% |
| Peritoneal Dialysis Complication |
4.9% |
| Pneumonia |
4.9% |
| Transplant Rejection |
4.9% |
| Urinary Tract Infection |
4.9% |
| General Physical Health Deterioration |
3.7% |
| Haemodynamic Instability |
3.7% |
| Hepatitis Acute |
3.7% |
| Mononeuropathy Multiplex |
3.7% |
| Pancytopenia |
3.7% |
| Pulmonary Oedema |
3.7% |
| Skin Discolouration |
3.7% |
| Tachycardia |
3.7% |
|
| Interacting |
| Atrial Fibrillation |
29.4% |
| Gout |
17.6% |
| Hypertension |
17.6% |
| Peripheral Arterial Occlusive Disease |
11.8% |
| Dyslipidaemia |
5.9% |
| Oedema Peripheral |
5.9% |
| Pain In Extremity |
5.9% |
| Renal Impairment |
5.9% |
|
| Renal Failure Acute |
66.7% |
| International Normalised Ratio Increased |
33.3% |
|
